Related references
Note: Only part of the references are listed.Biomarkers in the development of anti-angiogenic therapies for ovarian cancer
Fharat A. Raja et al.
CANCER TREATMENT REVIEWS (2012)
Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics
Kristy L. Shield-Artin et al.
PROTEOMICS CLINICAL APPLICATIONS (2012)
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Bethany E. Schaffer et al.
CANCER RESEARCH (2010)
Ovarian cancer biomarkers for molecular biosensors and translational medicine
K. Stephen Suh et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Beyond CA125: the coming of age of ovarian cancer biomarkers
Dimitra Sasaroli et al.
BIOMARKERS IN MEDICINE (2009)
Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry
Ayako Negishi et al.
CANCER SCIENCE (2009)
The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras
V. M. Ho et al.
ONCOGENE (2009)
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
Digant Gupta et al.
JOURNAL OF OVARIAN RESEARCH (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
Biological activities of C1 inhibitor
Alvin E. Davis et al.
MOLECULAR IMMUNOLOGY (2008)
CA125 in ovarian cancer
Nathalie Scholler et al.
BIOMARKERS IN MEDICINE (2007)
Ceruloplasmin and what it might do
J. Healy et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
pRb2/p130: A new candidate for retinoblastoma tumor formation
G. De Falco et al.
ONCOGENE (2006)
Proteases and protease inhibitors: a balance of activities in host-pathogen interaction
Peter B. Armstrong
IMMUNOBIOLOGY (2006)
New tumor markers: CA125 and beyond
RC Bast et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Characterization of serum biomarkers for detection of early stage ovarian cancer
KR Kozak et al.
PROTEOMICS (2005)
Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer:: role of inflammation in cancer-related anemia
A Macciò et al.
BLOOD (2005)
Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas
J Kitawaki et al.
HUMAN REPRODUCTION (2005)
Identification of hemoglobin-α and -β subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer
WS Ahn et al.
CANCER SCIENCE (2005)
Selective activation of ceruloplasmin promoter in ovarian tumors: Potential use for gene therapy
CM Lee et al.
CANCER RESEARCH (2004)
Towards a proteomic analysis of atopic dermatitis: A two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts
YD Park et al.
PROTEOMICS (2004)
Antigens secreted from Mycobacterium tuberculosis:: Identification by proteomics approach and test for diagnostic marker
YY Bahk et al.
PROTEOMICS (2004)
Share Paper
